Fig. 6From: Revealing active components, action targets and molecular mechanism of Gandi capsule for treating diabetic nephropathy based on network pharmacology strategyBaicalin and wogonoside altered the phosphorylation and expression of AMPK, PI3K, and AKT in HG-induced human podocyte cells. a Human podocyte cells were preconditioned with HG (30 mmol/L) for 0, 5, 10, 15, and 30 min and measured by western blotting. b Human podocyte cells were preconditioned with HG (30 mmol/L) for 0, 0.5, 1, 2, and 3 h, and measured by western blotting. c Human podocyte cells were preconditioned with baicalin (5 or10 mg/L) or wogonoside (5 or10 mg/L) for 12 h and incubated for 0.5 h with different treatments. The expression of AKT and p-AKT was measured by western blotting. d Human podocyte cells were preconditioned with baicalin (5 or10 mg/L) or wogonoside (5 or10 mg/L) for 12 h and incubated for 2 h with different treatments. The expression of AMPK, p-AMPK, PI3K, and p-PI3K was measured by western blotting. Control: normal glucose condition (5 mM D-glucose); DMSO:dimethyl sulfoxide; HG: high glucose condition (30 mM D-glucose); MA (mannitol, 5 mM D-glucose + 25 mM mannitol)Back to article page